The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

AlphaBiomics received Innovate UK grant to develop roadmap for NHS adoption of RxSelex™

 Read more here

The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

Winner of the 2018 European Innovation Quickfire Challenge (read more)